Nabriva Therapeutics plc Inventory Write-down
Nabriva Therapeutics plc reported Inventory Write-down of $7.53 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2023-10-19
- 2023-06-30: Inventory Write-down 6 month $7.53M.
| Period end | Inventory Write-down 6 month |
|---|---|
| 2023-06-30 | $7.53M 10-Q · filed 2023-10-19 |